{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T18:00:45Z","timestamp":1775152845824,"version":"3.50.1"},"reference-count":24,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,3,12]]},"DOI":"10.1097\/qad.0b013e3282f5e062","type":"journal-article","created":{"date-parts":[[2009,3,5]],"date-time":"2009-03-05T15:47:24Z","timestamp":1236268044000},"page":"625-635","source":"Crossref","is-referenced-by-count":92,"title":["Transmission of drug-resistant HIV-1 in Europe remains limited to single classes"],"prefix":"10.1097","volume":"22","member":"276","reference":[{"key":"R2-9-20210130","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1086\/367989","article-title":"Transmission fitness of drug-resistant human immunodeficiency virus and the prevalence of resistance in the antiretroviral-treated population","volume":"187","author":"Leigh Brown","year":"2003","journal-title":"J Infect Dis"},{"key":"R3-9-20210130","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1097\/00002030-200411050-00011","article-title":"Antiretroviral resistance and high-risk transmission behavior among HIV-positive patients in clinical care","volume":"18","author":"Kozal","year":"2004","journal-title":"AIDS"},{"key":"R4-9-20210130","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1097\/01.qai.0000155201.51232.2e","article-title":"French national sentinel survey of antiretroviral drug resistance in patients with HIV-1 primary infection and in antiretroviral-naive chronically infected patients in 2001\u20132002","volume":"38","author":"Descamps","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R5-9-20210130","doi-asserted-by":"crossref","first-page":"2174","DOI":"10.1086\/420789","article-title":"The epidemiology of antiretroviral drug resistance among drug-naive HIV-1-infected persons in 10 US cities","volume":"189","author":"Weinstock","year":"2004","journal-title":"J Infect Dis"},{"key":"R10-9-20210130","doi-asserted-by":"crossref","first-page":"3497","DOI":"10.1093\/nar\/gkg500","article-title":"Multiple sequence alignment with the Clustal series of programs","volume":"31","author":"Chenna","year":"2003","journal-title":"Nucl Acids Res"},{"key":"R11-9-20210130","first-page":"51","article-title":"Update of the drug resistance mutations in HIV-1: 2005","volume":"13","author":"Johnson","year":"2005","journal-title":"Top HIV Med"},{"key":"R12-9-20210130","doi-asserted-by":"crossref","first-page":"3797","DOI":"10.1093\/bioinformatics\/bti607","article-title":"An automated genotyping system for analysis of HIV-1 and other microbial sequences","volume":"21","author":"de Oliveira","year":"2005","journal-title":"Bioinformatics"},{"key":"R13-9-20210130","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/135965350200700206","article-title":"A genotypic drug resistance interpretation algorithm that significantly predicts therapy response in HIV-1-infected patients","volume":"7","author":"Van Laethem","year":"2002","journal-title":"Antivir Ther"},{"key":"R14-9-20210130","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/nar\/gkg100","article-title":"Human immunodeficiency virus reverse transcriptase and protease sequence database","volume":"31","author":"Rhee","year":"2003","journal-title":"Nucl Acids Res"},{"key":"R15-9-20210130","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1097\/01.aids.0000189878.97480.ed","article-title":"Detection of minor populations of drug-resistant HIV-1 in acute seroconverters","volume":"19","author":"Metzner","year":"2005","journal-title":"AIDS"},{"key":"R16-9-20210130","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1089\/088922202753472801","article-title":"Underestimation of HIV type 1 drug resistance mutations: results from the ENVA-2 genotyping proficiency program","volume":"18","author":"Schuurman","year":"2002","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R17-9-20210130","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1128\/JVI.76.4.1753-1761.2002","article-title":"Persistence and fitness of multidrug-resistant human immunodeficiency virus type 1 acquired in primary infection","volume":"76","author":"Brenner","year":"2002","journal-title":"J Virol"},{"key":"R18-9-20210130","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/135965350400900301","article-title":"Persistence of multidrug-resistant HIV-1 without antiretroviral treatment 2 years after sexual transmission","volume":"9","author":"Delaugerre","year":"2004","journal-title":"Antivir Ther"},{"key":"R19-9-20210130","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1097\/01.aids.0000131391.91468.ff","article-title":"Persistence of primary drug resistance among recently HIV-1 infected adults","volume":"18","author":"Barbour","year":"2004","journal-title":"AIDS"},{"key":"R20-9-20210130","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/135965350601100208","article-title":"Evolution of transmitted HIV-1 with drug-resistance mutations in the absence of therapy: effects on CD4+ T-cell count and HIV-1 RNA load","volume":"11","author":"Bezemer","year":"2006","journal-title":"Antivir Ther"},{"key":"R21-9-20210130","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1086\/432916","article-title":"Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management","volume":"192","author":"Wensing","year":"2005","journal-title":"J Infect Dis"},{"key":"R22-9-20210130","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1097\/01.qai.0000209899.05126.e4","article-title":"The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes","volume":"41","author":"van de Vijver","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R24-9-20210130","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJMoa013552","article-title":"Antiretroviral-drug resistance among patients recently infected with HIV","volume":"347","author":"Little","year":"2002","journal-title":"N Engl J Med"},{"key":"R25-9-20210130","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/jama.288.2.181","article-title":"Time trends in primary HIV-1 drug resistance among recently infected persons","volume":"288","author":"Grant","year":"2002","journal-title":"JAMA"},{"key":"R26-9-20210130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/01.qai.0000219290.49152.6a","article-title":"Tracking the prevalence of transmitted antiretroviral drug-resistant HIV-1: a decade of experience","volume":"41","author":"Shet","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R27-9-20210130","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1136\/bmj.38665.534595.55","article-title":"Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study","volume":"331","author":"Cane","year":"2005","journal-title":"BMJ"},{"key":"R28-9-20210130","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1097\/00002030-200401230-00012","article-title":"Risk of failure in patients with 215 HIV-1 revertants starting their first thymidine analog-containing highly active antiretroviral therapy","volume":"18","author":"Violin","year":"2004","journal-title":"AIDS"},{"key":"R29-9-20210130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1177\/135965350400900308","article-title":"The influence of protease inhibitor resistance profiles on selection of HIV therapy in treatment-naive patients","volume":"9","author":"Turner","year":"2004","journal-title":"Antivir Ther"},{"key":"R30-9-20210130","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1128\/JVI.68.3.1660-1666.1994","article-title":"Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapy","volume":"68","author":"Richman","year":"1994","journal-title":"J Virol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-200803120-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,11]],"date-time":"2024-03-11T03:28:28Z","timestamp":1710127708000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-200803120-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,3,12]]},"references-count":24,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e3282f5e062","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2008,3,12]]}}}